nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Cisplatin—peripheral nervous system neoplasm	0.261	1	CbGbCtD
Octreotide—SSTR2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0159	0.0888	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00727	0.0405	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00595	0.0331	CbGpPWpGaD
Octreotide—SSTR5—brainstem—peripheral nervous system neoplasm	0.00524	0.199	CbGeAlD
Octreotide—SSTR3—brainstem—peripheral nervous system neoplasm	0.00502	0.191	CbGeAlD
Octreotide—SSTR4—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00468	0.0261	CbGpPWpGaD
Octreotide—SSTR1—brainstem—peripheral nervous system neoplasm	0.00397	0.151	CbGeAlD
Octreotide—SSTR3—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00355	0.0198	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.0034	0.0189	CbGpPWpGaD
Octreotide—SSTR2—brainstem—peripheral nervous system neoplasm	0.00338	0.128	CbGeAlD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00314	0.0175	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00302	0.0168	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00278	0.0155	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.0026	0.0145	CbGpPWpGaD
Octreotide—SSTR5—cerebellum—peripheral nervous system neoplasm	0.00258	0.0983	CbGeAlD
Octreotide—SSTR3—cerebellum—peripheral nervous system neoplasm	0.00248	0.0942	CbGeAlD
Octreotide—SSTR4—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00239	0.0133	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00238	0.0133	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00229	0.0128	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00228	0.0127	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.0021	0.0117	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00209	0.0116	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00202	0.0113	CbGpPWpGaD
Octreotide—SSTR1—cerebellum—peripheral nervous system neoplasm	0.00196	0.0745	CbGeAlD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00192	0.0107	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00187	0.0104	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00181	0.0101	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00178	0.00988	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00174	0.00967	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00174	0.00967	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00171	0.00953	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00167	0.00927	CbGpPWpGaD
Octreotide—SSTR2—cerebellum—peripheral nervous system neoplasm	0.00166	0.0633	CbGeAlD
Octreotide—SSTR3—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00159	0.00888	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00157	0.00874	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00156	0.00869	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00155	0.00864	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00154	0.00858	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00153	0.00851	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00148	0.00823	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00142	0.00792	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00141	0.00786	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00136	0.00759	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00136	0.00755	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00135	0.00752	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00135	0.00749	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00129	0.00718	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00128	0.00712	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00125	0.00697	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00123	0.00683	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00118	0.00655	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00118	0.00655	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00114	0.00637	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00113	0.00628	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00107	0.00598	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00107	0.00595	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00106	0.00588	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00103	0.00571	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00102	0.0057	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00102	0.0057	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.001	0.00557	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000982	0.00547	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00094	0.00523	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00093	0.00518	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00093	0.00518	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000923	0.00514	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000909	0.00506	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000892	0.00496	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000892	0.00496	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000871	0.00485	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000858	0.00478	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000855	0.00476	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000839	0.00467	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000815	0.00453	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000808	0.0045	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000804	0.00447	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000791	0.0044	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000781	0.00435	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00078	0.00434	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000776	0.00432	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000758	0.00422	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000744	0.00414	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00073	0.00406	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000725	0.00404	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000712	0.00396	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000705	0.00392	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.0007	0.0039	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000695	0.00387	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000693	0.00386	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000683	0.0038	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000676	0.00376	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00066	0.00367	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000651	0.00362	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000639	0.00356	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000639	0.00356	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000624	0.00347	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000609	0.00339	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000607	0.00338	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000606	0.00337	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000599	0.00334	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000588	0.00327	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000559	0.00311	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000553	0.00308	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000553	0.00308	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000552	0.00307	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00055	0.00306	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00055	0.00306	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000548	0.00305	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000546	0.00304	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000531	0.00296	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000527	0.00293	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000527	0.00293	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000511	0.00284	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000507	0.00282	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000505	0.00281	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000482	0.00268	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000467	0.0026	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00046	0.00256	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000448	0.00249	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000441	0.00246	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000431	0.0024	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.00043	0.00239	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000418	0.00233	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000416	0.00232	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000413	0.0023	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000403	0.00224	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000401	0.00223	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000399	0.00222	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000391	0.00218	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000386	0.00215	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000384	0.00214	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000381	0.00212	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000368	0.00205	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000366	0.00203	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000361	0.00201	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000355	0.00198	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000354	0.00197	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00035	0.00195	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000342	0.00191	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000335	0.00187	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000328	0.00183	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000327	0.00182	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000327	0.00182	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000326	0.00181	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000316	0.00176	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000311	0.00173	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000311	0.00173	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000302	0.00168	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000289	0.00161	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000287	0.0016	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000285	0.00159	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000277	0.00154	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000254	0.00141	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000247	0.00137	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000245	0.00137	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000244	0.00136	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000237	0.00132	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000235	0.00131	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000227	0.00126	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000226	0.00126	CbGpPWpGaD
Octreotide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000412	CcSEcCtD
Octreotide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000219	0.000411	CcSEcCtD
Octreotide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.00041	CcSEcCtD
Octreotide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00041	CcSEcCtD
Octreotide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000218	0.000409	CcSEcCtD
Octreotide—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000406	CcSEcCtD
Octreotide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000216	0.000406	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000216	0.0012	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000216	0.0012	CbGpPWpGaD
Octreotide—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000404	CcSEcCtD
Octreotide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000214	0.0004	CcSEcCtD
Octreotide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.000399	CcSEcCtD
Octreotide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000399	CcSEcCtD
Octreotide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000398	CcSEcCtD
Octreotide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000396	CcSEcCtD
Octreotide—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000396	CcSEcCtD
Octreotide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000396	CcSEcCtD
Octreotide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000211	0.000395	CcSEcCtD
Octreotide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.000394	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00021	0.00117	CbGpPWpGaD
Octreotide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000208	0.000391	CcSEcCtD
Octreotide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000208	0.00039	CcSEcCtD
Octreotide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00039	CcSEcCtD
Octreotide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000389	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000207	0.00115	CbGpPWpGaD
Octreotide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000387	CcSEcCtD
Octreotide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000207	0.000387	CcSEcCtD
Octreotide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000386	CcSEcCtD
Octreotide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000206	0.000386	CcSEcCtD
Octreotide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000205	0.000385	CcSEcCtD
Octreotide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000384	CcSEcCtD
Octreotide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000382	CcSEcCtD
Octreotide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000204	0.000382	CcSEcCtD
Octreotide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000381	CcSEcCtD
Octreotide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000381	CcSEcCtD
Octreotide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000202	0.000378	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000202	0.00112	CbGpPWpGaD
Octreotide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000201	0.000378	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.0002	0.00111	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0002	0.000375	CcSEcCtD
Octreotide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000375	CcSEcCtD
Octreotide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.0002	0.000375	CcSEcCtD
Octreotide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000374	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000199	0.00111	CbGpPWpGaD
Octreotide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000372	CcSEcCtD
Octreotide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000198	0.000372	CcSEcCtD
Octreotide—Pain—Etoposide—peripheral nervous system neoplasm	0.000198	0.000372	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000198	0.0011	CbGpPWpGaD
Octreotide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000371	CcSEcCtD
Octreotide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000371	CcSEcCtD
Octreotide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000371	CcSEcCtD
Octreotide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000368	CcSEcCtD
Octreotide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.000368	CcSEcCtD
Octreotide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000196	0.000367	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000366	CcSEcCtD
Octreotide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000364	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000194	0.00108	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000361	CcSEcCtD
Octreotide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000361	CcSEcCtD
Octreotide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000192	0.00036	CcSEcCtD
Octreotide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000359	CcSEcCtD
Octreotide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000358	CcSEcCtD
Octreotide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000191	0.000358	CcSEcCtD
Octreotide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000357	CcSEcCtD
Octreotide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.000357	CcSEcCtD
Octreotide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000355	CcSEcCtD
Octreotide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000189	0.000355	CcSEcCtD
Octreotide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000189	0.000355	CcSEcCtD
Octreotide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.000354	CcSEcCtD
Octreotide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000353	CcSEcCtD
Octreotide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.000351	CcSEcCtD
Octreotide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.000351	CcSEcCtD
Octreotide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000186	0.000349	CcSEcCtD
Octreotide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000349	CcSEcCtD
Octreotide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000349	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000346	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000185	0.00103	CbGpPWpGaD
Octreotide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000184	0.000345	CcSEcCtD
Octreotide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000344	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000184	0.00102	CbGpPWpGaD
Octreotide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000344	CcSEcCtD
Octreotide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000183	0.000343	CcSEcCtD
Octreotide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000183	0.000343	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000343	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000343	CcSEcCtD
Octreotide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000343	CcSEcCtD
Octreotide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000341	CcSEcCtD
Octreotide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000182	0.000341	CcSEcCtD
Octreotide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000181	0.00034	CcSEcCtD
Octreotide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00034	CcSEcCtD
Octreotide—Rash—Vincristine—peripheral nervous system neoplasm	0.00018	0.000338	CcSEcCtD
Octreotide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00018	0.000338	CcSEcCtD
Octreotide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000338	CcSEcCtD
Octreotide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000337	CcSEcCtD
Octreotide—Headache—Vincristine—peripheral nervous system neoplasm	0.000179	0.000336	CcSEcCtD
Octreotide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000334	CcSEcCtD
Octreotide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000333	CcSEcCtD
Octreotide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000331	CcSEcCtD
Octreotide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000331	CcSEcCtD
Octreotide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00033	CcSEcCtD
Octreotide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000324	CcSEcCtD
Octreotide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000323	CcSEcCtD
Octreotide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000171	0.00032	CcSEcCtD
Octreotide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00032	CcSEcCtD
Octreotide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00017	0.000319	CcSEcCtD
Octreotide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000318	CcSEcCtD
Octreotide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000318	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000318	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000169	0.000943	CbGpPWpGaD
Octreotide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000317	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000316	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000315	CcSEcCtD
Octreotide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000312	CcSEcCtD
Octreotide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000166	0.000312	CcSEcCtD
Octreotide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00031	CcSEcCtD
Octreotide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000164	0.000307	CcSEcCtD
Octreotide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000306	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000306	CcSEcCtD
Octreotide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000303	CcSEcCtD
Octreotide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000302	CcSEcCtD
Octreotide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00016	0.0003	CcSEcCtD
Octreotide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000299	CcSEcCtD
Octreotide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000299	CcSEcCtD
Octreotide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000298	CcSEcCtD
Octreotide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000298	CcSEcCtD
Octreotide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000159	0.000297	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000296	CcSEcCtD
Octreotide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000294	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000294	CcSEcCtD
Octreotide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000294	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000156	0.000871	CbGpPWpGaD
Octreotide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000293	CcSEcCtD
Octreotide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00029	CcSEcCtD
Octreotide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000289	CcSEcCtD
Octreotide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000153	0.000287	CcSEcCtD
Octreotide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000287	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000286	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000153	0.00085	CbGpPWpGaD
Octreotide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000283	CcSEcCtD
Octreotide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000282	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00015	0.000835	CbGpPWpGaD
Octreotide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000281	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00028	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000278	CcSEcCtD
Octreotide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000277	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000147	0.000821	CbGpPWpGaD
Octreotide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000147	0.000276	CcSEcCtD
Octreotide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000276	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000276	CcSEcCtD
Octreotide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000276	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000146	0.000815	CbGpPWpGaD
Octreotide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000274	CcSEcCtD
Octreotide—Rash—Etoposide—peripheral nervous system neoplasm	0.000146	0.000274	CcSEcCtD
Octreotide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000146	0.000274	CcSEcCtD
Octreotide—Headache—Etoposide—peripheral nervous system neoplasm	0.000145	0.000272	CcSEcCtD
Octreotide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000272	CcSEcCtD
Octreotide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000271	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000144	0.000801	CbGpPWpGaD
Octreotide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000269	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000143	0.000798	CbGpPWpGaD
Octreotide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000268	CcSEcCtD
Octreotide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000268	CcSEcCtD
Octreotide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000268	CcSEcCtD
Octreotide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000267	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000142	0.000791	CbGpPWpGaD
Octreotide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000265	CcSEcCtD
Octreotide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000264	CcSEcCtD
Octreotide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000262	CcSEcCtD
Octreotide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000139	0.00026	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00026	CcSEcCtD
Octreotide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000259	CcSEcCtD
Octreotide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000138	0.000258	CcSEcCtD
Octreotide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000258	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000256	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000255	CcSEcCtD
Octreotide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000254	CcSEcCtD
Octreotide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000254	CcSEcCtD
Octreotide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000254	CcSEcCtD
Octreotide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000254	CcSEcCtD
Octreotide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000253	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000252	CcSEcCtD
Octreotide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000251	CcSEcCtD
Octreotide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000249	CcSEcCtD
Octreotide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000248	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000248	CcSEcCtD
Octreotide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000248	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.00013	0.000725	CbGpPWpGaD
Octreotide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000244	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00013	0.000723	CbGpPWpGaD
Octreotide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000244	CcSEcCtD
Octreotide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000244	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000243	CcSEcCtD
Octreotide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000242	CcSEcCtD
Octreotide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000241	CcSEcCtD
Octreotide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00024	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000128	0.00071	CbGpPWpGaD
Octreotide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000239	CcSEcCtD
Octreotide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000239	CcSEcCtD
Octreotide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000238	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000238	CcSEcCtD
Octreotide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000238	CcSEcCtD
Octreotide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000237	CcSEcCtD
Octreotide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000235	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000235	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000235	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000235	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000234	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000233	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000232	CcSEcCtD
Octreotide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000232	CcSEcCtD
Octreotide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00023	CcSEcCtD
Octreotide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000225	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000225	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00012	0.000667	CbGpPWpGaD
Octreotide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000224	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000119	0.000663	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000119	0.00066	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000222	CcSEcCtD
Octreotide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000222	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000221	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000118	0.000655	CbGpPWpGaD
Octreotide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000221	CcSEcCtD
Octreotide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00022	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00022	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000219	CcSEcCtD
Octreotide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000219	CcSEcCtD
Octreotide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000218	CcSEcCtD
Octreotide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000217	CcSEcCtD
Octreotide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000217	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000215	CcSEcCtD
Octreotide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000214	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000114	0.000633	CbGpPWpGaD
Octreotide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000212	CcSEcCtD
Octreotide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00021	CcSEcCtD
Octreotide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00021	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000112	0.000622	CbGpPWpGaD
Octreotide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000208	CcSEcCtD
Octreotide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000208	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000111	0.000617	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000205	CcSEcCtD
Octreotide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000204	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000109	0.000605	CbGpPWpGaD
Octreotide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000202	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000108	0.000599	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000107	0.000596	CbGpPWpGaD
Octreotide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000201	CcSEcCtD
Octreotide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000201	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.0002	CcSEcCtD
Octreotide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000199	CcSEcCtD
Octreotide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000198	CcSEcCtD
Octreotide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000196	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000104	0.00058	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000195	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000194	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000103	0.000574	CbGpPWpGaD
Octreotide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000193	CcSEcCtD
Octreotide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000193	CcSEcCtD
Octreotide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000193	CcSEcCtD
Octreotide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000193	CcSEcCtD
Octreotide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000193	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000101	0.000561	CbGpPWpGaD
Octreotide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000186	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.87e-05	0.000549	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.000184	CcSEcCtD
Octreotide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.57e-05	0.000179	CcSEcCtD
Octreotide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.000179	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.5e-05	0.000529	CbGpPWpGaD
Octreotide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000178	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000178	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.46e-05	0.000527	CbGpPWpGaD
Octreotide—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000175	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.31e-05	0.000518	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.24e-05	0.000514	CbGpPWpGaD
Octreotide—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000172	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.15e-05	0.000509	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.11e-05	0.000507	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.02e-05	0.000502	CbGpPWpGaD
Octreotide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000167	CcSEcCtD
Octreotide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.000166	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.77e-05	0.000488	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.71e-05	0.000485	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.65e-05	0.000481	CbGpPWpGaD
Octreotide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000162	CcSEcCtD
Octreotide—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000161	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.53e-05	0.000475	CbGpPWpGaD
Octreotide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000159	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.45e-05	0.00047	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.4e-05	0.000468	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.39e-05	0.000467	CbGpPWpGaD
Octreotide—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000155	CcSEcCtD
Octreotide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.000154	CcSEcCtD
Octreotide—Rash—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000154	CcSEcCtD
Octreotide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000153	CcSEcCtD
Octreotide—Headache—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000153	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.06e-05	0.000448	CbGpPWpGaD
Octreotide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000149	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.74e-05	0.000431	CbGpPWpGaD
Octreotide—Nausea—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000145	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.69e-05	0.000428	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.67e-05	0.000427	CbGpPWpGaD
Octreotide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000143	CcSEcCtD
Octreotide—Rash—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000142	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000142	CcSEcCtD
Octreotide—Headache—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000141	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.15e-05	0.000398	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000134	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.08e-05	0.000394	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.9e-05	0.000384	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.62e-05	0.000368	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.6e-05	0.000367	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.59e-05	0.000367	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.33e-05	0.000352	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.87e-05	0.000327	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.83e-05	0.000324	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.61e-05	0.000312	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.59e-05	0.000311	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.42e-05	0.000301	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.18e-05	0.000288	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.96e-05	0.000276	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.57e-05	0.000255	CbGpPWpGaD
